Ercan ES, Kandulu R, Uslu E, Ardic UA, Yazici KU, Basay BK, et al. Prevalence and diagnostic stability of ADHD and ODD in Turkish children: a 4-year longitudinal study. Child Adolesc Psychiatry Ment Health. 2013;7:30.
Article
PubMed
PubMed Central
Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington DC: American Psychiatric Publishing; 2013.
Book
Google Scholar
Becker KD, Chorpita BF, Daleiden EL. Improvement in symptoms versus functioning: how do our best treatments measure up? Adm Policy Ment Health. 2011;38:440–58.
Article
PubMed
Google Scholar
Battaglia S, Orsolini S, Borgomaneri S, Barbieri R, Diciotti S, di Pellegrino G. Characterizing cardiac autonomic dynamics of fear learning in humans. Psychophysiology. 2022;e14122.
Battaglia S, Serio G, Scarpazza C, D’Ausilio A, Borgomaneri S. Frozen in (e) motion: how reactive motor inhibition is influenced by the emotional content of stimuli in healthy and psychiatric populations. Behav Res Ther. 2021;146: 103963.
Article
PubMed
Google Scholar
Battaglia S, Fabius JH, Moravkova K, Fracasso A, Borgomaneri S. The neurobiological correlates of gaze perception in healthy individuals and neurologic patients. Biomedicines. 2022;10:627.
Article
PubMed
PubMed Central
Google Scholar
Tanaka M, Spekker E, Szabó Á, Polyák H, Vécsei L. Modelling the neurodevelopmental pathogenesis in neuropsychiatric disorders. Bioactive kynurenines and their analogues as neuroprotective agents—in celebration of 80th birthday of Professor Peter Riederer. J Neural Transm. 2022;9:1313.
Google Scholar
Saccaro LF, Schilliger Z, Perroud N, Piguet C. Inflammation, anxiety, and stress in attention-deficit/hyperactivity disorder. Biomedicines. 2021;9:1313.
Article
CAS
PubMed
PubMed Central
Google Scholar
Weiss M, Childress A, Mattingly G, Nordbrock E, Kupper RJ, Adjei AL. Relationship between symptomatic and functional improvement and remission in a treatment response to stimulant trial. J Child Adolesc Psychopharmacol. 2018;28:521–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Coghill DR, Joseph A, Sikirica V, Kosinski M, Bliss C, Huss M. Correlations between clinical trial outcomes based on symptoms, functional impairments, and quality of life in children and adolescents with ADHD. J Atten Disord. 2019;23:1578–91.
Article
PubMed
Google Scholar
Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128:1007.
European Medicine Agency. Guideline on the clinical investigation of medicinal products for the treatment of attention deficit hyperactivity disorder (ADHD). 2008. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/08/WC500095686.pdf
Coghill DR, Banaschewski T, Soutullo C, Cottingham MG, Zuddas A. Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2017;26:1283–307.
Article
PubMed
PubMed Central
Google Scholar
Dittmann RW, Cardo E, Nagy P, Anderson CS, Bloomfield R, Caballero B, et al. Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study. CNS Drugs. 2013;27:1081–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hervas A, Huss M, Johnson M, McNicholas F, van Stralen J, Sreckovic S, et al. Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial. Eur Neuropsychopharmacol. 2014;24:1861–72.
Article
CAS
PubMed
Google Scholar
Ni H-C, Lin Y-J, Gau SS-F, Huang H-C, Yang L-K. An open-label, randomized trial of methylphenidate and atomoxetine treatment in adults with ADHD. J Atten Disord. 2017;21:27–39.
Article
PubMed
Google Scholar
Shang C-Y, Shih H-H, Pan Y-L, Lin H-Y, Gau SS-F. Comparative efficacy of methylphenidate and atomoxetine on social adjustment in youths with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2020;30:148–58.
Article
CAS
PubMed
Google Scholar
Faltinsen E, Zwi M, Castells X, Gluud C, Simonsen E, Storebø OJ. Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look. BMJ Evid Based Med. 2019;24:99–102.
Article
PubMed
Google Scholar
Hollingshead AB. Two factor index of social position. New Haven: Hollingshead; 1957.
Google Scholar
Turgay A. Disruptive behavior disorders child and adolescent screening and rating scales for children, adolescents, parents and teachers. West Bloomfield (Michigan): Integrative Therapy Institute Publication; 1994.
Google Scholar
Ercan E. Development of a test battery for the assessment of attention deficit hyperactivity disorder. Turk J Child Adolesc Psychiatry. 2001;8:132–44.
Google Scholar
Weiss M, Dickson R, Wasdell M, editors. Weiss functional impairment rating scale-parent report (WFIRS-P). American Psychiatric Association 158th Annual Meeting; 2004.
Tarakçıoğlu MC, Memik NC, Olgun NN, Aydemir Ö, Weiss MD. Turkish validity and reliability study of the Weiss functional impairment rating scale-parent report. Atten Defic Hyperact Disord. 2015;7:129–39.
Article
PubMed
Google Scholar
Kaalund-Brok K, Houmann TB, Hebsgaard MB, Lauritsen M-BG, Lundstrøm LH, Grønning H, et al. Outcomes of a 12-week ecologically valid observational study of first treatment with methylphenidate in a representative clinical sample of drug naïve children with ADHD. PLoS ONE. 2021;16:e0253727.
Article
CAS
PubMed
PubMed Central
Google Scholar
Feingold A. Confidence interval estimation for standardized effect sizes in multilevel and latent growth modeling. J Consult Clin Psychol. 2015;83:157.
Article
PubMed
Google Scholar
Fuentes J, Danckaerts M, Cardo E, Puvanendran K, Berquin P, De Bruyckere K, et al. Long-term quality-of-life and functioning comparison of atomoxetine versus other standard treatment in pediatric attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2013;33:766–74.
Article
CAS
PubMed
Google Scholar
Nagy P, Häge A, Coghill DR, Caballero B, Adeyi B, Anderson CS, et al. Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate. Eur Child Adolesc Psychiatry. 2016;25:141–9.
Article
PubMed
Google Scholar
Banaschewski T, Soutullo C, Lecendreux M, Johnson M, Zuddas A, Hodgkins P, et al. Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorder. CNS Drugs. 2013;27:829–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Coghill DR, Werner-Kiechle T, Farahbakhshian S, Bliss C, Robertson B, Huss M. Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses. Eur Child Adolesc Psychiatry. 2021;30:809–21.
Article
PubMed
Google Scholar
Haugan A-LJ, Sund AM, Thomsen PH, Lydersen S, Nøvik TS. Psychometric properties of the Weiss Functional Impairment Rating Scale parent and self-reports in a Norwegian clinical sample of adolescents treated for ADHD. Nord J Psychiatry. 2021;75:63–72.
Article
PubMed
Google Scholar
Gajria K, Kosinski M, Sikirica V, Huss M, Livote E, Reilly K, et al. Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder. Health Qual Life Outcomes. 2015;13:1–11.
Article
Google Scholar
De Boo GM, Prins PJ. Social incompetence in children with ADHD: possible moderators and mediators in social-skills training. Clin Psychol Rev. 2007;27:78–97.
Article
PubMed
Google Scholar
Matza LS, Johnston JA, Faries DE, Malley KG, Brod M. Responsiveness of the adult attention-deficit/hyperactivity disorder quality of life scale (AAQoL). Qual Life Res. 2007;16:1511–20.
Article
PubMed
Google Scholar
Kutlu A, Ardic UA, Ercan ES. Effect of methylphenidate on emotional dysregulation in children with attention-deficit/hyperactivity disorder + oppositional defiant disorder/conduct disorder. J Clin Psychopharmacol. 2017;37:220–5.
Article
CAS
PubMed
Google Scholar
Reimherr FW, Marchant BK, Strong RE, Hedges DW, Adler L, Spencer TJ, et al. Emotional dysregulation in adult ADHD and response to atomoxetine. Biol Psychiatry. 2005;58:125–31.
Article
CAS
PubMed
Google Scholar
Maoz H, Tsviban L, Gvirts HZ, Shamay-Tsoory SG, Levkovitz Y, Watemberg N, et al. Stimulants improve theory of mind in children with attention deficit/hyperactivity disorder. J Psychopharmacol. 2014;28:212–9.
Article
PubMed
CAS
Google Scholar
Demirci E, Erdogan A. Is emotion recognition the only problem in ADHD? Effects of pharmacotherapy on face and emotion recognition in children with ADHD. Atten Defic Hyperact Disord. 2016;8:197–204.
Article
PubMed
Google Scholar
Mckenzie A, Meshkat S, Lui LM, Ho R, Di Vincenzo JD, Ceban F, et al. The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: a systematic review. J Psychiatr Res. 2022;149:252–9.
Article
PubMed
Google Scholar
Waxmonsky JG, Waschbusch DA, Pelham WE, Draganac-Cardona L, Rotella B, Ryan L. Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2010;71:1535–51.
Article
CAS
PubMed
Google Scholar
Brown RT, Perwien A, Faries DE, Kratochvil CJ, Vaughan BS. Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning. Clin Pediatr (Phila). 2006;45:819–27.
Article
Google Scholar
Arnett JJ. Emerging adulthood: the winding road from the late teens through the twenties. Oxford: Oxford University Press; 2014.
Book
Google Scholar
Canu WH, Hartung CM, Stevens AE, Lefler EK. Psychometric properties of the Weiss Functional Impairment Rating Scale: evidence for utility in research, assessment, and treatment of ADHD in emerging adults. J Atten Disord. 2020;24:1648–60.
Article
PubMed
Google Scholar
Jangmo A, Stålhandske A, Chang Z, Chen Q, Almqvist C, Feldman I, et al. Attention-deficit/hyperactivity disorder, school performance, and effect of medication. J Am Acad Child Adolesc Psychiatry. 2019;58:423–32.
Article
PubMed
PubMed Central
Google Scholar
Wu C-S, Shang C-Y, Lin H-Y, Gau SS-F. Differential treatment effects of methylphenidate and atomoxetine on executive functions in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2021;31:187–96.
Article
CAS
PubMed
Google Scholar
Prasad V, Brogan E, Mulvaney C, Grainge M, Stanton W, Sayal K. How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2013;22:203–16.
Article
PubMed
Google Scholar
Savill NC, Buitelaar JK, Anand E, Day KA, Treuer T, Upadhyaya HP, et al. The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research. CNS Drugs. 2015;29:131–51.
Article
CAS
PubMed
Google Scholar
Nasser A, Hull JT, Liranso T, Busse GD, Melyan Z, Childress AC, et al. The effect of viloxazine extended-release capsules on functional impairments associated with attention-deficit/hyperactivity disorder (ADHD) in children and adolescents in four phase 3 placebo-controlled trials. Neuropsychiatr Dis Treat. 2021;17:1751.
Article
PubMed
PubMed Central
Google Scholar
Spekker E, Tanaka M, Szabó Á, Vécsei L. Neurogenic inflammation: The participant in migraine and recent advancements in translational research. Biomedicines. 2021;10:76.
Article
PubMed
PubMed Central
CAS
Google Scholar
Tanaka M, Tóth F, Polyák H, Szabó Á, Mándi Y, Vécsei L. Immune influencers in action: metabolites and enzymes of the tryptophan-kynurenine metabolic pathway. Biomedicines. 2021;9:734.
Article
CAS
PubMed
PubMed Central
Google Scholar
Martos D, Tuka B, Tanaka M, Vécsei L, Telegdy G. Memory enhancement with kynurenic acid and its mechanisms in neurotransmission. Biomedicines. 2022;10:849.
Article
CAS
PubMed
PubMed Central
Google Scholar
Faraone SV, Schachar RJ, Barkley RA, Nullmeier R, Sallee FR. Early morning functional impairments in stimulant-treated children with attention-deficit/hyperactivity disorder versus controls: impact on the family. J Child Adolesc Psychopharmacol. 2017;27:715–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sallee FR. Early morning functioning in stimulant-treated children and adolescents with attention-deficit/hyperactivity disorder, and its impact on caregivers. J Child Adolesc Psychopharmacol. 2015;25:558–65.
Article
PubMed
PubMed Central
Google Scholar
Chronis AM, Pelham WE, Gnagy EM, Roberts JE, Aronoff HR. The impact of late-afternoon stimulant dosing for children with ADHD on parent and parent-child domains. J Clin Child Adolesc Psychol. 2003;32:118–26.
Article
PubMed
Google Scholar
Svanborg P, Thernlund G, Gustafsson PA, Hägglöf B, Schacht A, Kadesjö B. Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents. Eur Child Adolesc Psychiatry. 2009;18:725–35.
Article
PubMed
PubMed Central
Google Scholar
Wells KC, Chi TC, Hinshaw SP, Epstein JN, Pfiffner L, Nebel-Schwalm M, et al. Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol. 2006;74:649.
Article
PubMed
Google Scholar
Daley D, Van der Oord S, Ferrin M, Cortese S, Danckaerts M, Doepfner M, et al. Practitioner review: current best practice in the use of parent training and other behavioural interventions in the treatment of children and adolescents with attention deficit hyperactivity disorder. J Child Psychol Psychiatry. 2018;59:932–47.
Article
PubMed
Google Scholar
Stein MA, Waldman ID, Charney E, Aryal S, Sable C, Gruber R, et al. Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts. J Child Adolesc Psychopharmacol. 2011;21:581–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Maziade M, Rouleau N, Lee B, Rogers A, Davis L, Dickson R. Atomoxetine and neuropsychological function in children with attention-deficit/hyperactivity disorder: results of a pilot study. J Child Adolesc Psychopharmacol. 2009;19:709–18.
Article
PubMed
Google Scholar
Nunnally JC. Psychometric theory 3E. New York: Tata McGraw-Hill education; 1994.
Google Scholar
Mazzone L, Postorino V, Reale L, Guarnera M, Mannino V, Armado M, et al. Self-esteem evaluation in children and adolescents suffering from ADHD. Clin Pract Epidemiol Ment Health. 2013;9:96–102.
Article
PubMed
PubMed Central
Google Scholar
Dose C, Hautmann C, Doepfner M. Functional impairment in children with externalizing behavior disorders: psychometric properties of the Weiss functional impairment rating scale–parent report in a German clinical sample. J Atten Disord. 2019;23:1546–56.
Article
PubMed
Google Scholar
Moss CM, Metzger KB, Carey ME, Blum NJ, Curry AE, Power TJ. Chronic care for attention-deficit/hyperactivity disorder: clinical management from childhood through adolescence. J Dev Behav Pediatr. 2020;41:S99–104.
Article
PubMed
PubMed Central
Google Scholar
Romer D. Adolescent risk taking, impulsivity, and brain development: implications for prevention. Dev Psychobiol. 2010;52:263–76.
PubMed
PubMed Central
Google Scholar
McQuade JD, Murray-Close D, Shoulberg EK, Hoza B. Working memory and social functioning in children. J Exp Child Psychol. 2013;115:422–35.
Article
PubMed
Google Scholar
Jassi A, Lenhard F, Krebs G, Gumpert M, Jolstedt M, Andrén P, et al. The work and social adjustment scale, youth and parent versions: psychometric evaluation of a brief measure of functional impairment in young people. Child Psychiatry Hum Dev. 2020;51:453–60.
Article
PubMed
PubMed Central
Google Scholar
Levi-Shachar O, Gvirts HZ, Goldwin Y, Bloch Y, Shamay-Tsoory S, Zagoory-Sharon O, et al. The effect of methylphenidate on social cognition and oxytocin in children with attention deficit hyperactivity disorder. Neuropsychopharmacology. 2020;45:367–73.
Article
PubMed
CAS
Google Scholar
Fantozzi P, Sesso G, Muratori P, Milone A, Masi G. Biological bases of empathy and social cognition in patients with attention-deficit/hyperactivity disorder: a focus on treatment with psychostimulants. Brain Sci. 2021;11:1399.
Article
CAS
PubMed
PubMed Central
Google Scholar
Camsari DD, Kirkovski M, Croarkin PE. Therapeutic applications of noninvasive neuromodulation in children and adolescents. Psychiatr Clin North Am. 2018;41:465–77.
Article
PubMed Central
Google Scholar
Hodgkins P, Lloyd A, Erder MH, Setyawan J, Weiss MD, Sasané R, et al. Estimating minimal important differences for several scales assessing function and quality of life in patients with attention-deficit/hyperactivity disorder. CNS Spectr. 2017;22:31–40.
Article
PubMed
Google Scholar
Weiss MD, McBride NM, Craig S, Jensen P. Conceptual review of measuring functional impairment: findings from the Weiss Functional Impairment Rating Scale. Evid Based Ment Health. 2018;21:155–64.
Article
PubMed
PubMed Central
Google Scholar